Efficacy and tolerability of almotriptan in menstrual migraine: A comment

Expert Opinion on Pharmacotherapy

Volumn 12, Issue 15, 2011, Pages 2279-2281

  Lionetto, Luana ^a   Fiorillo, Martina ^a   Martelletti, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CYTOCHROME P450; ELETRIPTAN; FLAVIN MONOOXYGENASE 3; ITRACONAZOLE; KETOCONAZOLE; PLACEBO; RIZATRIPTAN; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE; ZOLMITRIPTAN;

ABSENCE OF SIDE EFFECTS; ANALGESIA; AREA UNDER THE CURVE; BINDING AFFINITY; BRAIN STEM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG TOLERABILITY; DRUG URINE LEVEL; ENZYME ACTIVITY; GENETIC VARIABILITY; HUMAN; LIVER DISEASE; MAXIMUM PLASMA CONCENTRATION; MENSTRUAL MIGRAINE; META ANALYSIS (TOPIC); NAUSEA; NOCICEPTION; PHARMACOGENOMICS; PHONOPHOBIA; PHOTOPHOBIA; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; TRIGEMINAL NUCLEUS; UNSPECIFIED SIDE EFFECT; VASOCONSTRICTION; VOMITING;

ANALGESICS, NON-NARCOTIC; FEMALE; HUMANS; MENSTRUATION; MIGRAINE WITHOUT AURA; SEROTONIN 5-HT1 RECEPTOR AGONISTS; TRYPTAMINES;

EID: 80052886662     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2011.602342     Document Type: Review

References (18)

1. Bartolini M, Giamberardino MA, Lisotto C, et al. A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain 2011;12:361-8
2. Ferrari A, Tiraferri I, Neri L, Sternieri E. Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. J Headache Pain 2011;12:5-12
3. Bussone G, Allais G, Castagnoli Gabellari I, Benedetto C. Almotriptan for menstrually related migraine. Expert Opin Pharmacother 2011;12:1933-43
4. Gentile G, Borro M, Lala N, et al. Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain 2010;11:431-5
5. Tfelt-Hansen P. Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment. J Headache Pain 2011;12:275-80
6. Sullivan E, Bushnell C. Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep 2010;14:376-84
7. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002;22:633-58 (Pubitemid 36609333)
8. Tepper SJ, Rapoport AM, Sheftell FD. Mechanisms of action of the 5-HT1B/1D receptor agonists. Arch Neurol 2002;59:1084-8 (Pubitemid 34755820)
9. Geraud G, Keywood C, Senard JM. Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. Headache 2003;43:376-88 (Pubitemid 36417768)
10. Loder E. Triptan therapy in migraine. N Engl J Med 2010;363:63-70
11. Fleishaker JC, Herman BD, Carel BJ, Azie NE. Interaction between ketoconazole and almotriptan in healthy volunteers. J Clin Pharmacol 2003;43:423-7 (Pubitemid 36368784)
12. McEnroe JD, Fleishaker JC. Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine. Clin Pharmacokinet 2005;44:237-46 (Pubitemid 40477787)
13. Gentile G, Borro M, Simmaco M, et al. Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy. Expert Opin Drug Metab Toxicol 2011;7:39-47
14. Gentile G, Missori S, Borro M, et al. Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine. J Headache Pain 2010;11:151-6
15. Allena M, Katsarava Z, Nappi G. COMOESTAS Consortium. From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries. J Headache Pain 2009;10:71-6
16. Russell MB. What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information? J Headache Pain 2011;12:89-90
17. Hagen K, Jensen R, Bøe MG, et al. Medication overuse headache: a critical review of end points in recent follow-up studies. J Headache Pain 2010;11:373-7
18. Calhoun A, Ford S. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache 2008;48:1186-93